摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,5-二丙基咪唑烷-2,4-二酮 | 36033-33-7

中文名称
5,5-二丙基咪唑烷-2,4-二酮
中文别名
——
英文名称
5,5-dipropylimidazolidine-2,4-dione
英文别名
5,5-Dipropyl-imidazolidin-2,4-dion;5,5-Dipropyl-imidazolidine-2,4-dione
5,5-二丙基咪唑烷-2,4-二酮化学式
CAS
36033-33-7
化学式
C9H16N2O2
mdl
MFCD03951076
分子量
184.238
InChiKey
TVKULRRHIFBSPZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188-191 °C
  • 密度:
    1.021±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.777
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:999ce7133bef9fc63361a7cc0ac8a2a7
查看

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids
    摘要:
    Previous structure-activity and NMR studies on nociceptin/orphanin FQ (N/OFQ) demonstrated that Aib substitution of Ala(7) and/or Ala(11) increases the peptide potency through an alpha helix structure induction mechanism. On these bases we synthesised and evaluated pharmacologically in the mouse vas deferens assay a series of N/OFQ-NH2 analogues substituted in position 7 and 11 with C alpha,alpha-disubstituted cyclic, linear and branched amino acids. None of the 20 novel N/OFQ analogues produced better results than [Aib(7)]N/OFQ-NH2. Thus, this substitution was combined with other chemical modifications known to modulate peptide potency and/or efficacy generating compound 21 [Nphe(1)Aib(7) Arg(14) Lys(15)] N/OFQ-NH2 (coded as UFP- 111), compound 22 [(pF)Phe(4) Aib(7) Arg(14) Lys(15)] N/OFQ-NH2 (UFP-112) and compound 23 [Phe psi(CH2-NH)Gly(2) (pF)Phe(4)Aib(7)Arg(14)Lys(15)]N/OFQ-NH2 (UFP- 113). These novel peptides behaved as highly potent NOP receptor ligands showing full (UFP- 112) and partial (UFP- 113) agonist and pure antagonist (UFP- 111) activities in a series of in vitro functional assays performed on pharmacological preparations expressing native as well as recombinant NOP receptors. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.04.026
  • 作为产物:
    描述:
    2-propyl-2-ureido-valeronitrile 在 盐酸 作用下, 生成 5,5-二丙基咪唑烷-2,4-二酮
    参考文献:
    名称:
    DE310427
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Stabilised compositions having and antibacterial activity
    申请人:——
    公开号:US20030186955A1
    公开(公告)日:2003-10-02
    A stabilised composition having antibacterial, antiviral and/or antifungal activity, said composition comprising silver ions and a ligand, characterised in that the composition comprises a complex of silver and a ligand selected from the group consisting of 5,5-disubstituted hydantoins in which the substituents do not comprise conjugated unsaturated bonds and barbituric acid and derivatives thereof stabilising silver ions against reduction to free silver in a hydrophilic environment, and that the composition has a solubility in water higher than 10 mg Ag/l is stable during sterilisation and retains the activity without giving rise to darkening or discoloration of the dressing during storage.
    具有抗菌、抗病毒和/或抗真菌活性的稳定化合物,该化合物包含银离子和配体,其特征在于该化合物包含银和配体的复合物,所述配体选自5,5-二取代咪唑烷酮(其取代基不包括共轭不饱和键)和巴比妥酸及其衍生物,稳定银离子以防止在亲水环境中还原为自由银,并且该化合物在水中的溶解度高于10毫克Ag/l,在灭菌过程中稳定,并且在贮存期间不会导致敷料变黑或变色。
  • Methods and systems for uniform control of bromine concentrations in water
    申请人:——
    公开号:US20030102271A1
    公开(公告)日:2003-06-05
    Reduced stabilization time of oxidation-reduction potential is achieved in a recreational body of water by baseloading bromide ions and dialkylhydantoin prior to biocidal treatment of the water body with N,N′-dihalo-5,5-dialkylhydantoin.
    在用 N,N′-二卤代-5,5-二烷基海因对水体进行杀菌处理之前,先对溴离子和二烷基海因进行基荷处理,从而缩短娱乐水体氧化还原电位的稳定时间。
  • Supramolecular Architectures in 5,5′-Substituted Hydantoins: Crystal Structures and Hirshfeld Surface Analyses
    作者:Basab Chattopadhyay、Alok K. Mukherjee、N. Narendra、H. P. Hemantha、Vommina V. Sureshbabu、Madeliene Helliwell、Monika Mukherjee
    DOI:10.1021/cg100706n
    日期:2010.10.6
    A series of three 5,5'-substituted hydantoin derivatives (1-3) were synthesized, and their crystal structures were solved using single-crystal synchrotron/powder-crystal X-ray diffraction data with a detailed analysis oil Hirshfeld surfaces and fingerprint plots facilitating a comparison of intermolecular interactions in building different supramolecular architectures. A comparison of supramolecular assembly in the compounds with that in similar 5,5'-substituted hydantoins in the Cambridge Structural Database (CSD) has been presented. The crystal packing in compounds 1-3 containing complementary hydrogen bonding groups, i.e. the amino NH donors and carbonyl 0 acceptors, exhibits three types of supramolecular synthons. In the dipropyl substituted hydantoin (1), intermolecular N-H center dot center dot center dot O hydrogen bonds with only one carbonyl O atom acting as a double acceptor generate a one-dimensional C-1(1)(4)C-1(1)(4)[R-2(2)(8)] network propagating along the [100] direction, while in 3, a 5-spiro fused hydantoin, the cyclic R-2(2)(8) motifs self-organize through pairs of N-H center dot center dot center dot O hydrogen bonds to form a C-2(2)(9)[R-2(2)(8)][R-2(2)(8)] framework running along the [1-10] direction. The molecular assembly in 2. with a dibutyl substitution at the hydantoin C-5 position, produces R-4(4)(17) synthons, which are edge-fused to form two-dimensional molecular sheets in the (100) plane. The formation of a supramolecular architecture built with an R-4(4)(17) synthon is unprecedented among the substituted hydantoin structures in the CSD.
  • Errera, Gazzetta Chimica Italiana, 1896, vol. 26 I, p. 201
    作者:Errera
    DOI:——
    日期:——
  • Preliminary biological studies of several aliphatic amino acid analogs
    作者:C. J. Abshire、G. Planet
    DOI:10.1021/jm00273a004
    日期:1972.3
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英